E
Eugenia Nikolsky
Researcher at Technion – Israel Institute of Technology
Publications - 141
Citations - 17047
Eugenia Nikolsky is an academic researcher from Technion – Israel Institute of Technology. The author has contributed to research in topics: Percutaneous coronary intervention & Myocardial infarction. The author has an hindex of 50, co-authored 141 publications receiving 15364 citations. Previous affiliations of Eugenia Nikolsky include Lenox Hill Hospital & Columbia University Medical Center.
Papers
More filters
Journal ArticleDOI
A risk score to predict bleeding in patients with acute coronary syndromes.
Roxana Mehran,Stuart J. Pocock,Eugenia Nikolsky,Tim Clayton,George Dangas,Ajay J. Kirtane,Helen Parise,Martin Fahy,Steven V. Manoukian,Frederick Feit,Magnus Ohman,Bernard Witzenbichler,Giulio Guagliumi,Alexandra J. Lansky,Gregg W. Stone +14 more
TL;DR: A simple risk score based on 6 baseline measures plus anticoagulation regimen identifies patients at increased risk for non-CABG-related bleeding and subsequent 1-year mortality, for whom appropriate treatment strategies can be implemented.
Journal ArticleDOI
Contrast-Induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables
George Dangas,Ioannis Iakovou,Eugenia Nikolsky,Eve Aymong,Gary S. Mintz,Nicholas Kipshidze,Alexandra J. Lansky,Issam Moussa,Gregg W. Stone,Jeffrey W. Moses,Martin B. Leon,Roxana Mehran +11 more
TL;DR: Regardless of the presence of CKD, baseline characteristics and periprocedural hemodynamic parameters predict CIN, and this complication is associated with worse in-hospital and 1-year outcomes.
Journal ArticleDOI
Prediction of mortality after primary percutaneous coronary intervention for acute myocardial infarction: the CADILLAC risk score.
Amir Halkin,Mandeep Singh,Eugenia Nikolsky,Cindy L. Grines,James E. Tcheng,Eulogio García,David A. Cox,Mark Turco,Thomas Stuckey,Yingo Na,Alexandra J. Lansky,Bernard J. Gersh,William W. O'Neill,Roxana Mehran,Gregg W. Stone +14 more
TL;DR: In AMI patients treated with primary PCI, seven risk factors readily available at the time of intervention accurately predict short- and long-term mortality.
Journal ArticleDOI
Vascular complications associated with arteriotomy closure devices in patients undergoing percutaneous coronary procedures: A meta-analysis
Eugenia Nikolsky,Roxana Mehran,Amir Halkin,Eve Aymong,Gary S. Mintz,Zoran Lasic,Manuela Negoita,Martin Fahy,Shoshana Krieger,Issam Moussa,Jeffrey W. Moses,Gregg W. Stone,Martin B. Leon,Stuart J. Pocock,T. George Dangas +14 more
TL;DR: In the setting of Dx angiography, the risk of access-site-related complications was similar for ACD compared with mechanical compression, and in theSetting of PCI, the rate of complications appeared higher with VasoSeal.
Journal ArticleDOI
Bivalirudin in patients undergoing primary angioplasty for acute myocardial infarction (HORIZONS-AMI): 1-year results of a randomised controlled trial
Roxana Mehran,Alexandra J. Lansky,Bernhard Witzenbichler,Giulio Guagliumi,Jan Z. Peruga,Bruce R. Brodie,Dariusz Dudek,Ran Kornowski,Franz Hartmann,Bernard J. Gersh,Stuart J. Pocock,S. Chiu Wong,Eugenia Nikolsky,Louise Gambone,Lynn Vandertie,Helen Parise,George Dangas,Gregg W. Stone +17 more
TL;DR: In patients with STEMI undergoing primary PCI, anticoagulation with bivalirudin reduced the rates of net adverse clinical events and major bleeding at 1 year compared with treatment with heparin plus a GPI.